助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   transdermal fentanyl 在 肿瘤学 分类中 的翻译结果: 查询用时:0.186秒
图标索引 在分类学科中查询
所有学科
肿瘤学
临床医学
外科学
感染性疾病及传染病
皮肤病与性病
心血管系统疾病
更多类别查询

图标索引 历史查询
 

transdermal fentanyl
相关语句
  芬太尼透皮贴剂
    Conclusion Transdermal fentanyl in pain treatment after interventional therapy for liver cancer has reliable efficacy,safety and less incident of adverse effects.
    结论芬太尼透皮贴剂用于治疗肝癌介入治疗后疼痛,疗效确切,安全可靠,不良反应小。
短句来源
    Clinical Application of Transdermal Fentanyl (Durogesic) for 67 Patients with Cancer Pain
    芬太尼透皮贴剂(多瑞吉)治疗癌痛临床应用67例观察
短句来源
    Clinical Study of Transdermal Fentanyl in Treatment of Cancer Pain
    芬太尼透皮贴剂治疗癌症疼痛的临床应用
短句来源
    The clinical use of transdermal fentanyl in treatment of cancer pain of lung cancer.
    芬太尼透皮贴剂治疗肺癌癌痛疗效分析
短句来源
    The Effects of Transdermal Fentanyl on 136 Patients with Moderate or Severe Cancer Pain
    芬太尼透皮贴剂治疗136例中重度癌痛疗效观察
短句来源
更多       
  透皮芬太尼
    The clinical use of transdermal fentanyl in the treatment of cancer pain
    透皮芬太尼在癌痛治疗中的应用
短句来源
    This report introduces the advantage of transdermal fentanyl and the ex perience about its use in cancer pain, which provides the theoretical basis for the clinical rational use of TTS fentanyl.
    本文综述了透皮芬太尼临床应用的优点及其在癌痛治疗的研究现状,从而为透皮芬太尼的临床应用提供了理论基础.
短句来源
  芬太尼透
    Conclusion Transdermal fentanyl in pain treatment after interventional therapy for liver cancer has reliable efficacy,safety and less incident of adverse effects.
    结论芬太尼透皮贴剂用于治疗肝癌介入治疗后疼痛,疗效确切,安全可靠,不良反应小。
短句来源
    Clinical Application of Transdermal Fentanyl (Durogesic) for 67 Patients with Cancer Pain
    芬太尼透皮贴剂(多瑞吉)治疗癌痛临床应用67例观察
短句来源
    Clinical Study of Transdermal Fentanyl in Treatment of Cancer Pain
    芬太尼透皮贴剂治疗癌症疼痛的临床应用
短句来源
    TRANSDERMAL FENTANYL FOR THE TREATFMENT OF CANCER PAIN IN 46 CASES
    芬太尼透皮贴治疗癌性疼痛46例疗效观察
短句来源
    The clinical use of transdermal fentanyl in treatment of cancer pain of lung cancer.
    芬太尼透皮贴剂治疗肺癌癌痛疗效分析
短句来源
更多       
  “transdermal fentanyl”译为未确定词的双语例句
    The median dosage of transdermal fentanyl is 7.5mg. The range of dosage was from 2.5mg to 7.5mg in 92.9% patients.
    芬太尼的中位剂量7.5mg,其中92.9%患者在2.5~10mg之内。
短句来源
    No severe side effects were noted. Conclusion The Ⅳ morphine / transdermal fentanyl conversion ratio is 31 (mg·day-1) : 1(mg·day-1) .
    结论 静脉吗啡日消耗量(mg/d)与芬太尼贴剂(mg/d)的转换比例是31:1。
短句来源
    The minimum dosage of Transdermal Fentanyl was 25 μg/h and the maximum 375 μg/h,average time of treatment was(90.5) d.
    治疗剂量最小为25μg/h,最大为375μg/h,平均治疗时间为90.5 d。
短句来源
    Results: Among all cases, 176(72.73%) received opioid therapy. In these patients, 134 (76.14%) took MS-Contin and 28 (15.91%) accepted transdermal fentanyl. Furthermore, weak opioids were taken by 14 (7.95%) patients.
    结果:176例(72.73%)用阿片止痛,其中134例(76.14%)用美施康定,28例(15.91%)用多瑞吉,14例(7.95%)用弱阿片,无阿片过量引起的死亡。
短句来源
    Clinical evaluation of the low-dose transdermal fentanyl for medium cancer pain
    小剂量芬太尼治疗中度癌痛疗效与满意度
短句来源
更多       
查询“transdermal fentanyl”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  transdermal fentanyl
Pain Recurrence on the Third Day after Application of a Transdermal Fentanyl Patch
      
Neurophysiologic disorders developed in three patients after discontinuation of transdermal fentanyl (TDF) at a daily dose of 0.6?mg (2.5?mg per a patch), although direct removal of a 2.5?mg patch is permitted by the manufacturer as the
      
Withdrawal symptom after discontinuation of transdermal fentanyl at a daily dose of 0.6 mg
      
Transdermal fentanyl treatment in opioid-na?ve cancer patients
      
Transdermal fentanyl seems to be a good palliative measure to treat CNH in patients who have advanced neoplasms.
      
更多          


To compare the efficiency and safety of transdermal fentanyl and sustained release morphine in the treatment of cancer pain,35 late stage cancer patients requiring opioid to relieve their cancer pain were enrolled into the self controlled study All the patients finished both transdermal fentanyl and sustained release morphine treatments The result showed that the remission rate,spectra and incidence of adverse reactions of transdermal...

To compare the efficiency and safety of transdermal fentanyl and sustained release morphine in the treatment of cancer pain,35 late stage cancer patients requiring opioid to relieve their cancer pain were enrolled into the self controlled study All the patients finished both transdermal fentanyl and sustained release morphine treatments The result showed that the remission rate,spectra and incidence of adverse reactions of transdermal fentanyl were similar to those of sustained release morphine However,a slightly significant(P<0 05)higher CR was observed for transdermal fentanyl In addition,the incidence of constipation was lower(P<0 05)in transdermal fentanyl treatment This suggested that as a WHO third stage cancer pain relieving modality,transdermal fentanyl display a comparable or slightly superior efficiency and safety profile for the management of cancer pain,and was more suitable for adult and children cancer pain cases who were unable to take opioids per oral

对 35例需强阿片类药镇痛的晚期癌痛患者进行芬太尼贴剂和口服控释吗啡的自身对照治疗 ,以比较两药控制癌痛的疗效及安全性。结果发现 ,两药治疗癌痛的总体缓解率、副反应谱及发生率均相近 ,但芬太尼贴剂控制癌痛的完全缓解率略高于口服控释吗啡 (P <0 .0 5 ) ,便秘的发生率略低 (P <0 .0 5 )。认为芬太尼透皮贴剂作为 WHO第三阶梯镇痛药具有与口服吗啡相近的疗效和安全性 ,尤其适用于不能口服镇痛药的癌痛患者。

Objective To investigate the response rate of transdermal fentanyl system or Duragesic to relieve bone pain by bone metastases. Methods From October 1999 to April 2000 60 patients suffered from middle or serious bone pain caused by bone metastases were randomly divided into 2.5mg and 5.0mg treatment groups. Each group consisted of 30 patients. Therapeutic response quality of life and toxic effect were studied. Results The response rate of 2.5mg and 5.0mg groups were 70% and 74% respectively....

Objective To investigate the response rate of transdermal fentanyl system or Duragesic to relieve bone pain by bone metastases. Methods From October 1999 to April 2000 60 patients suffered from middle or serious bone pain caused by bone metastases were randomly divided into 2.5mg and 5.0mg treatment groups. Each group consisted of 30 patients. Therapeutic response quality of life and toxic effect were studied. Results The response rate of 2.5mg and 5.0mg groups were 70% and 74% respectively. The initial time of effect of these two groups were 3.2 and 2.8 hours and it could be sustained for 53.4 and 60.6 hours respectively even without significant difference P>0.05. But the difference of bone pain score and Karnofsy value before and after treatment was significant P<0.05. The main toxic effects were nausea vomiting dizziness constipation somnolence etc. Conclusion Transdermal fentanyl system is one kind of effective analgesics for bone pain especially for middle and serious bone pain. Although the therapeutic effect of 2.5mg and 5.0mg dosage has no significant difference but the toxic effect of duragesic must be emphasized.

目的:观察芬太尼透皮贴剂治疗恶性肿瘤合并骨转移所致骨痛的效果。方法:从1999年10月起,将60例骨转移瘤伴有中度以上疼痛的患者随机分成2.5mg/贴和5.0mg/贴两个治疗组,每组30例,观察其止痛疗效、生活质量的变化及毒副作用。结果:两治疗组止痛显效率分别为70%和74%,平均起效时间分别为3.2和2.8小时,平均止痛持续时间分别为53.4和60.6小时,差异无显著性;骨痛和生活质量Karnofsy评分治疗前后差异有显著性;但两组之间比较,无统计学意义。芬太尼透皮贴剂常见的毒副作用是头晕、恶心呕吐、便秘、嗜睡等症状,并以5.0mg治疗组副作用大。结论:芬太尼贴剂作为长效麻醉止痛药,具有使用方便、疗效确定和毒副作用小的特点。虽然,2.5mg/贴和5.0mg/贴两个治疗组比较,差异无显著性;但从表面看,2.5mg/贴和5.0mg/贴两种剂型药物总有效率、其起效时间和持续时间略有差异,但毒副作用以5.0mg芬太尼为重。

Objective To evaluate the efficacy side effects and life quality changes of transdermal fetanyl in patients with cancer pain. Methods Sixty-seven patients with moderate or severe cancer pain were treated by transdermal fentanyl in this multi-center opening study. The pain intensity pain relief quality of life and side effects were studied at the beginning and the end of therapy. Results After treatment all the patients obtained moderate and upward remission. The excellent effective and moderate...

Objective To evaluate the efficacy side effects and life quality changes of transdermal fetanyl in patients with cancer pain. Methods Sixty-seven patients with moderate or severe cancer pain were treated by transdermal fentanyl in this multi-center opening study. The pain intensity pain relief quality of life and side effects were studied at the beginning and the end of therapy. Results After treatment all the patients obtained moderate and upward remission. The excellent effective and moderate rates were 50.7% 46.3% and 2.99% respectively. The side effects included lethargy constipation dizziness nausea and vomiting etc. No fatal serious adverse reactions appeared. The quality of life improved markedly. Conclusion Transdermal fentanyl Durogesic is a new type analgesic. The pain alleviated significantly and the side effects are mild. Durogesic can improve the quality of life markedly especially for alimentary tract cancer patients in whom oral administration is not available.

目的:在癌症疼痛患者中观察芬太尼贴剂(多瑞吉)的临床镇痛效果、不良反应及使用后患者生活质量的改善程度。方法:采用多中心开放研究。选取67例伴有中、重度疼痛的恶性肿瘤患者,使用芬太尼贴剂止痛。记录治疗前后的疼痛强度、生活质量评分和用药中的不良反应,加以归纳总结。结果:芬太尼贴剂使用后,全部患者均获中度以上缓解。其中完全缓解34例(50.70%),明显缓解31例(46.30%),中度缓解2例(2.99%)。不良反应有嗜睡、便秘、头晕、恶心呕吐等,无危及生命的严重不良反应出现。受试患者的生活质量得到明显改善。结论:芬太尼贴剂(多瑞吉,Durogesic)是一种新型癌痛控制剂。该药疼痛控制效果较好,不良反应轻微,能够明显改善癌症患者的生活质量。尤其适用于不能口服止痛药的患者。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关transdermal fentanyl的内容
在知识搜索中查有关transdermal fentanyl的内容
在数字搜索中查有关transdermal fentanyl的内容
在概念知识元中查有关transdermal fentanyl的内容
在学术趋势中查有关transdermal fentanyl的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社